Not PCa related but...great results f... - Fight Prostate Ca...

Fight Prostate Cancer

3,035 members1,516 posts

Not PCa related but...great results for a trial: personalized antigen vaccines gaining traction

Maxone73 profile image
0 Replies

A Phase 1 clinical trial has demonstrated the feasibility and potential of a personalized cancer vaccine (PCV) targeting renal cell carcinoma (RCC). The study, published in Nature, explores how individualized vaccines, designed to train the immune system to recognize a patient's unique tumor mutations (neoantigens), could enhance anti-tumor responses when combined with immune checkpoint inhibitors (ICIs).

Each patient’s tumor was genetically analyzed to identify neoantigens, which are mutations exclusive to cancer cells.

The selected neoantigens were formulated into a vaccine designed to activate the patient's T-cells against cancer.

The vaccine was administered alongside checkpoint inhibitors (ICI), such as anti-PD-1 therapies, to enhance the immune system’s ability to attack tumors.

Immune Response Monitoring: Scientists measured how well neoantigen-specific T-cells expanded and targeted cancer cells after vaccination.

Most patients developed a robust T-cell activation against the selected tumor antigens.

Some participants experienced tumor shrinkage or stable disease, indicating that the immune response had a functional impact.

The vaccine was well tolerated, with manageable immune-related side effects similar to those seen with existing immunotherapies.

"At a median follow-up of 40.2 months after surgery, none of the 9 participants enrolled in the study had a recurrence of RCC. No dose-limiting toxicities were observed. ", not bad at all for a kind of cancer that tends to have frequent recurrences.

nature.com/articles/s41586-...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
Read more about...

Not what you're looking for?

You may also like...

Researchers discover vaccine originally created for HIV may also combat [prostate] cancer!

from an X.com post Vipin M. Vashishtha @vipintukur "Researchers discover vaccine originally...
kainasar profile image

Phase 1 starting soon: IDOV-Immune oncolytic platform!

You know I love the oncolytic virus approach! IDOV-Immune is a promising experimental cancer...
Maxone73 profile image

The Take Home Message on Cujoe's Posting on CRISPR edited T cells--THIS IS HUGE AND IMPORTANT

This was the first EVER, sanctioned by the government, multiple gene editings to the human genome...
NPfisherman profile image

Cancer at the cell level Peter Attia

https://peterattiamd.com/keithflaherty2/?utm_source=podcast-email&utm_medium=email&utm_campaign=2308

Pick of the Month: JANX007, why?

Ok, I have been reviewing my notes and I must say that, even if it's still a phase 1 trial, I like...
Maxone73 profile image

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.